Ozono K - Search Results

1

Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey.

Takatani R, Kubota T, Minagawa M, Inoue D, Fukumoto S, Ozono K, Nakamura Y. Takatani R, et al. Among authors: ozono k. J Epidemiol. 2023 Nov 5;33(11):569-573. doi: 10.2188/jea.JE20220152. Epub 2023 Jan 31. J Epidemiol. 2023. PMID: 36123043 Free PMC article.

2

Hyperintensity of posterior pituitary on MR T1WI in a boy with central diabetes insipidus caused by missense mutation of neurophysin II gene.

Kubota T, Yamamoto T, Ozono K, Shimotsuji T. Kubota T, et al. Among authors: ozono k. Endocr J. 2001 Aug;48(4):459-63. doi: 10.1507/endocrj.48.459. Endocr J. 2001. PMID: 11603568 Free article.

3

[Regulation of bone mineralization by enzymes].

Kubota T, Ozono K. Kubota T, et al. Among authors: ozono k. Clin Calcium. 2004 Jun;14(6):23-7. Clin Calcium. 2004. PMID: 15577050 Review. Japanese.

4

[Osteoporosis associated with gene mutation].

Ozono K, Kubota T. Ozono K, et al. Clin Calcium. 2003 Dec;13(12):1523-9. Clin Calcium. 2003. PMID: 15775238 Japanese.

5

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.

Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T. Endo I, et al. Among authors: ozono k. Bone. 2008 Jun;42(6):1235-9. doi: 10.1016/j.bone.2008.02.014. Epub 2008 Mar 5. Bone. 2008. PMID: 18396126

6

Causes and differential diagnosis of hypocalcemia--recommendation proposed by expert panel supported by ministry of health, labour and welfare, Japan.

Fukumoto S, Namba N, Ozono K, Yamauchi M, Sugimoto T, Michigami T, Tanaka H, Inoue D, Minagawa M, Endo I, Matsumoto T. Fukumoto S, et al. Among authors: ozono k. Endocr J. 2008 Oct;55(5):787-94. doi: 10.1507/endocrj.k08e-076. Epub 2008 May 19. Endocr J. 2008. PMID: 18490837 Free article.

7

Lrp6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd.

Kubota T, Michigami T, Sakaguchi N, Kokubu C, Suzuki A, Namba N, Sakai N, Nakajima S, Imai K, Ozono K. Kubota T, et al. Among authors: ozono k. J Bone Miner Res. 2008 Oct;23(10):1661-71. doi: 10.1359/jbmr.080512. J Bone Miner Res. 2008. PMID: 18505367 Free article.

8

Wnt signaling in bone metabolism.

Kubota T, Michigami T, Ozono K. Kubota T, et al. Among authors: ozono k. J Bone Miner Metab. 2009;27(3):265-71. doi: 10.1007/s00774-009-0064-8. Epub 2009 Mar 31. J Bone Miner Metab. 2009. PMID: 19333681 Review.

9

Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta.

Kitaoka T, Namba N, Miura K, Kubota T, Ohata Y, Fujiwara M, Hirai H, Yamamoto T, Ozono K. Kitaoka T, et al. Among authors: ozono k. J Bone Miner Metab. 2011 Sep;29(5):598-605. doi: 10.1007/s00774-011-0262-z. Epub 2011 Feb 23. J Bone Miner Metab. 2011. PMID: 21344299 Clinical Trial.

10

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.

Miura K, Namba N, Fujiwara M, Ohata Y, Ishida H, Kitaoka T, Kubota T, Hirai H, Higuchi C, Tsumaki N, Yoshikawa H, Sakai N, Michigami T, Ozono K. Miura K, et al. Among authors: ozono k. PLoS One. 2012;7(8):e42180. doi: 10.1371/journal.pone.0042180. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22870295 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

532 results

Search Page